United States · FDA National Drug Code directory
Nicotine Mini
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63548-0262_096f4324-c2f9-4fa7-9e59-59396cf31149
- Product NDC
- 63548-0262
- Form
- LOZENGE
- Composition / generic term
- nicotine polacrilex
- Labeler
- PLD Acquisitions LLC DBA Avma Pharma Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190401
- Source listing expiry
- 20261231
Source-listed ingredients
- NICOTINE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BOTTLE, PLASTIC in 1 BOX (63548-0262-0) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 63548-0262-0
- 3 BOTTLE, PLASTIC in 1 BOX (63548-0262-1) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 63548-0262-1
- 1 BOTTLE, PLASTIC in 1 BOX (63548-0262-7) / 27 LOZENGE in 1 BOTTLE, PLASTIC · 63548-0262-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →